• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Minor disease features in neurofibromatosis type 1 (NF1) and their possible value in diagnosis of NF1 in children < or = 6 years and clinically suspected of having NF1. Neurofibromatosis team of Sophia Children's Hospital.1型神经纤维瘤病(NF1)的轻微疾病特征及其在诊断6岁及以下临床疑似患有NF1的儿童NF1中的可能价值。索菲亚儿童医院神经纤维瘤病团队。
J Med Genet. 1998 Aug;35(8):624-7. doi: 10.1136/jmg.35.8.624.
2
Diagnostic delay in neurofibromatosis type 1.1型神经纤维瘤病的诊断延迟
Eur J Pediatr. 1997 Jun;156(6):482-7. doi: 10.1007/s004310050644.
3
Predictive value of café au lait macules at initial consultation in the diagnosis of neurofibromatosis type 1.初诊时咖啡斑对1型神经纤维瘤病诊断的预测价值。
Arch Dermatol. 2009 Aug;145(8):883-7. doi: 10.1001/archdermatol.2009.169.
4
[Children with neurofibroma type 1 treated in the Children's Memorial Health Institute].在儿童纪念健康研究所接受治疗的1型神经纤维瘤患儿
Med Wieku Rozwoj. 2006 Jul-Sep;10(3 Pt 1):699-709.
5
Nevus Anemicus As an Additional Diagnostic Marker of Neurofibromatosis Type 1 in Childhood.贫血痣作为儿童1型神经纤维瘤病的附加诊断标志物。
Neuropediatrics. 2016 Jun;47(3):190-3. doi: 10.1055/s-0036-1579786. Epub 2016 Mar 28.
6
Juvenile xanthogranuloma and nevus anemicus in the diagnosis of neurofibromatosis type 1.幼年黄色肉芽肿和贫血性神经纤维瘤在 1 型神经纤维瘤病诊断中的作用。
JAMA Dermatol. 2014 Jan;150(1):42-6. doi: 10.1001/jamadermatol.2013.6434.
7
Cognitive features that distinguish preschool-age children with neurofibromatosis type 1 from their peers: a matched case-control study.认知特征将患有神经纤维瘤病 1 型的学龄前儿童与其同龄人区分开来:一项匹配的病例对照研究。
J Pediatr. 2013 Nov;163(5):1479-83.e1. doi: 10.1016/j.jpeds.2013.06.038. Epub 2013 Aug 1.
8
Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children.使用美国国立卫生研究院标准诊断儿童1型神经纤维瘤病。
Pediatrics. 2000 Mar;105(3 Pt 1):608-14. doi: 10.1542/peds.105.3.608.
9
[Neurofibromatosis type 1: more frequent and severe then usually thought].
Rev Assoc Med Bras (1992). 2009 Jul-Aug;55(4):394-9. doi: 10.1590/s0104-42302009000400012.
10
[Phenotypic and genetic features in neurofibromatosis type 1 in children].[儿童1型神经纤维瘤病的表型和遗传特征]
An Pediatr (Barc). 2015 Sep;83(3):173-82. doi: 10.1016/j.anpedi.2014.10.010. Epub 2014 Dec 23.

引用本文的文献

1
Café-Au-Lait Macules in Neurofibromatosis Type 1: Birthmark or Biomarker?1型神经纤维瘤病中的咖啡斑:胎记还是生物标志物?
Cancers (Basel). 2025 Apr 29;17(9):1490. doi: 10.3390/cancers17091490.
2
Neurofibromatosis-Noonan syndrome: a prospective monocentric study of 26 patients and literature review.神经纤维瘤病-努南综合征:26例患者的前瞻性单中心研究及文献综述
Orphanet J Rare Dis. 2025 Apr 27;20(1):201. doi: 10.1186/s13023-025-03706-3.
3
Association between neurofibromatosis type 1 and cerebrovascular diseases in children: A systematic review.神经纤维瘤病 1 型与儿童脑血管病的相关性:系统综述。
PLoS One. 2021 Jan 4;16(1):e0241096. doi: 10.1371/journal.pone.0241096. eCollection 2021.
4
Disruption of Critical Period Plasticity in a Mouse Model of Neurofibromatosis Type 1.神经纤维瘤病 1 型小鼠模型中关键期可塑性的破坏。
J Neurosci. 2020 Jul 8;40(28):5495-5509. doi: 10.1523/JNEUROSCI.2235-19.2020. Epub 2020 Jun 11.
5
Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966.神经纤维瘤病 1 型法国国家指南,基于自 1966 年以来的广泛文献回顾。
Orphanet J Rare Dis. 2020 Feb 3;15(1):37. doi: 10.1186/s13023-020-1310-3.
6
Bilateral and symmetrical anteromedial bowing of the lower limbs in a patient with neurofibromatosis type-I.一名I型神经纤维瘤病患者双下肢出现双侧对称性前内侧弓形弯曲。
Case Rep Orthop. 2015;2015:425970. doi: 10.1155/2015/425970. Epub 2015 Feb 28.
7
Pediatric neurofibromatosis 1 and parental stress: a multicenter study.小儿神经纤维瘤病 1 型与父母压力:一项多中心研究。
Neuropsychiatr Dis Treat. 2014 Jan 22;10:141-6. doi: 10.2147/NDT.S55518. eCollection 2014.
8
Neurofibromatosis: chronological history and current issues.神经纤维瘤病:历史沿革与当前问题
An Bras Dermatol. 2013 May-Jun;88(3):329-43. doi: 10.1590/abd1806-4841.20132125.
9
Nutraceuticals safety and efficacy in migraine without aura in a population of children affected by neurofibromatosis type I.神经纤维瘤病 I 型患儿偏头痛无先兆人群中营养保健品的安全性和疗效。
Neurol Sci. 2013 Nov;34(11):1905-9. doi: 10.1007/s10072-013-1403-z. Epub 2013 Mar 27.
10
Neurofibromatosis type 1 and infantile spasms.1型神经纤维瘤病与婴儿痉挛症。
Childs Nerv Syst. 2009 Feb;25(2):211-6. doi: 10.1007/s00381-008-0706-5. Epub 2008 Sep 19.

本文引用的文献

1
Diagnostic delay in neurofibromatosis type 1.1型神经纤维瘤病的诊断延迟
Eur J Pediatr. 1997 Jun;156(6):482-7. doi: 10.1007/s004310050644.
2
Somatic mosaicism for deletion of the entire NF1 gene identified by FISH.通过荧光原位杂交(FISH)鉴定出的整个NF1基因缺失的体细胞镶嵌现象。
Hum Genet. 1997 Feb;99(2):209-13. doi: 10.1007/s004390050341.
3
Somatic mosaicism in a patient with neurofibromatosis type 1.1型神经纤维瘤病患者的体细胞镶嵌现象。
Am J Hum Genet. 1996 Mar;58(3):484-90.
4
An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes.1型神经纤维瘤病(NF1)表达变异分析:修饰基因的证据
Am J Hum Genet. 1993 Aug;53(2):305-13.
5
Molecular basis of neurofibromatosis type 1 (NF1): mutation analysis and polymorphisms in the NF1 gene.1型神经纤维瘤病(NF1)的分子基础:NF1基因的突变分析与多态性
Hum Mutat. 1994;4(2):83-101. doi: 10.1002/humu.1380040202.
6
Neurofibromatosis type 1 due to germ-line mosaicism in a clinically normal father.临床正常父亲的生殖系嵌合体导致的1型神经纤维瘤病。
N Engl J Med. 1994 Nov 24;331(21):1403-7. doi: 10.1056/NEJM199411243312102.
7
Penetrance of von Recklinghausen neurofibromatosis: a distinction between predecessors and descendants.冯雷克林霍增氏神经纤维瘤病的外显率:前辈与后代的区别。
Am J Hum Genet. 1988 Feb;42(2):284-9.
8
A genetic study of von Recklinghausen neurofibromatosis in south east Wales. II. Guidelines for genetic counselling.威尔士东南部冯·雷克林豪森神经纤维瘤病的遗传学研究。II. 遗传咨询指南。
J Med Genet. 1989 Nov;26(11):712-21. doi: 10.1136/jmg.26.11.712.
9
A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity.威尔士东南部冯·雷克林豪森神经纤维瘤病的遗传学研究。I. 患病率、健康状况、突变率以及亲代传递对严重程度的影响。
J Med Genet. 1989 Nov;26(11):704-11. doi: 10.1136/jmg.26.11.704.
10
The diagnosis of neurofibromatosis-1 in the child under the age of 6 years.
Am J Dis Child. 1989 Jun;143(6):717-9. doi: 10.1001/archpedi.1989.02150180099028.

1型神经纤维瘤病(NF1)的轻微疾病特征及其在诊断6岁及以下临床疑似患有NF1的儿童NF1中的可能价值。索菲亚儿童医院神经纤维瘤病团队。

Minor disease features in neurofibromatosis type 1 (NF1) and their possible value in diagnosis of NF1 in children < or = 6 years and clinically suspected of having NF1. Neurofibromatosis team of Sophia Children's Hospital.

作者信息

Cnossen M H, Moons K G, Garssen M P, Pasmans N M, de Goede-Bolder A, Niermeijer M F, Grobbee D E

机构信息

Department of General Paediatrics, University Hospital Sophia/Dijkzigt, Erasmus University Rotterdam, The Netherlands.

出版信息

J Med Genet. 1998 Aug;35(8):624-7. doi: 10.1136/jmg.35.8.624.

DOI:10.1136/jmg.35.8.624
PMID:9719365
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1051384/
Abstract

OBJECTIVE

To establish the frequency of minor disease features in children with neurofibromatosis type 1 (NF1) and to evaluate the value of minor disease features in children < or = 6 years with a suspected diagnosis of NF1, considering that the disease is virtually 100% penetrant at 6 years of age.

DESIGN

During this 10 year, prospective, multidisciplinary, follow up study, 209 children suspected of having NF1 were examined; 150 were diagnosed with NF1 and 59 were not. The present analysis included children in whom NF1 was considered to be present at 6 years of age (n=85) and children without NF1 at 6 years of age (n=42).

RESULTS

The minor disease features macrocephaly (52.9%), short stature (24.7%), hypertelorism (63.5%), and thorax abnormalities (37.6%) were highly prevalent in children with NF1 and significantly associated with a diagnosis of NF1 at 6 years of age. In addition, the mean number of minor disease features was significantly higher in children with NF1 at 6 years of age compared to the group without a diagnosis at 6 years of age (mean 1.8 v 0.8, p<0.001). Moreover, children with three or more minor disease features were all diagnosed with NF1 under the age of 6 years. Multivariate analysis using a logistic regression model showed that macrocephaly, short stature, hypertelorism, and thorax abnormalities were all independently associated with the presence of NF1 at 6 years of age.

CONCLUSION

In children with insufficient diagnostic criteria aged < or = 6 years, documentation of minor disease features may be a helpful aid in predicting the diagnosis of NF1 in years to come.

摘要

目的

确定1型神经纤维瘤病(NF1)患儿轻微疾病特征的发生率,并评估这些轻微疾病特征在疑似NF1的6岁及以下儿童中的价值,因为该疾病在6岁时几乎100%会发病。

设计

在这项为期10年的前瞻性、多学科随访研究中,对209名疑似患有NF1的儿童进行了检查;其中150名被诊断为NF1,59名未被诊断为NF1。目前的分析包括6岁时被认为患有NF1的儿童(n = 85)和6岁时未患NF1的儿童(n = 42)。

结果

轻微疾病特征巨头症(52.9%)、身材矮小(24.7%)、眼距增宽(63.5%)和胸部异常(37.6%)在NF1患儿中非常普遍,且与6岁时NF1的诊断显著相关。此外,6岁时患有NF1的儿童的轻微疾病特征平均数量显著高于6岁时未被诊断的儿童组(平均1.8对0.8,p<0.001)。此外,具有三种或更多轻微疾病特征的儿童在6岁前均被诊断为NF1。使用逻辑回归模型的多变量分析表明,巨头症、身材矮小、眼距增宽和胸部异常均与6岁时NF1的存在独立相关。

结论

在诊断标准不足的6岁及以下儿童中,记录轻微疾病特征可能有助于预测未来几年NF1的诊断。